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ABSTRACT
We describe a novel method, Coincident Sequence
Cloning (CSC), which permits the selective recovery of
common sequences shared between two complex and
partially coincident DNA mixtures. We evaluate this
method by integrating human DNA with DNA from a
mouse-human somatic cell hybrid, and we recover
exclusively human DNA products which are all
represented in the hybrid genome. CSC strategies
should be useful in addressing many highly complex
problems in genome analysis.
INTRODUCTION
Approaches to mammalian genome analysis commonly employ
'enrichment strategies' to achieve an initial significant reduction
in the level ofDNA complexity. One example of such a strategy
would be the use of somatic cell genetics to isolate subgenomic
fragments, and another the construction of cDNA libraries to
access sequences having tissue restricted expression profiles. The
degree of genome simplification attainable by these approaches
is however limited, and therefore, the comprehensive analysis
of the resulting material remains a considerable task.
A conceptual solution to this problem would be to apply
different enrichment strategies sequentially to achieve a
multiplicative degree of purification. Unfortunately, the majority
ofDNA enrichment procedures can not be combined in this way.
We have therefore considered an alternative means by which the
enrichment characteristics of two different strategies can be
coupled, that is, to integrate directly a pair of enriched mixtures
in such a way as to recover only those sequences common to
both. This approach could be employed in any situation where
sequences of interest are shared between complex DNA resources
such as cDNA libraries, somatic cell hybrid DNA or cloned
genomic DNA. To this end we have developed a method for the
selective recovery of the common DNA shared between two
mixtures. We propose to call this method Coincident Sequence
Cloning (CSC).
In this report we evaluate CSC by integrating human DNA
sequences with total DNA from a mouse-human somatic cell
hybrid containing only 5% of the human genome. The products
recovered in this experiment are exclusively human and all map
back to the human component of the hybrid genome.
MATERIALS AND METHODS
Southern blotting and hybridisation
Southern blots were prepared as described elsewhere (1). In vitro
labelling was by the oligo-labelling method (2). Hybridisations
were performed at 68°C for 16 hours in a buffer containing
5 x SSC (1 x SSC comprises 0. 15M NaCl, 0.015M sodium citrate
pH7.4), 5xDenhart's solution, 0.1% SDS, 0.1% PPi, 10%
dextran sulphate and 50yg/ml denatured sonicated salmon sperm
DNA. Unless otherwise stated, post-hybridisation washes were
conducted at 65°C in 0.lxSSC, 0.1% SDS.
Preparative agarose gel electrophoresis
Samples DNA's were separated on low melting temperature
agarose gels in TAE buffer (0.04M Tris/acetate pH8.0, 0.001M
EDTA). Regions of the gel containing DNA fragments to be
recovered were excised and melted for 5 minutes at 65°C. NaCl
and agarase (Calbiochem) were added to 50mM and 100u/ml
respectively, and the sample placed at 37°C for 4-16 hours.
The DNA was finally recovered by phenol extraction and ethanol
precipitation.
Oligonucleotide sequences
The following oligonucleotides were synthesised by standard
phosphoramidite chemistry and employed in the CSC procedure
as described in the text:
5'capture oligo;
5' GGACGGGTCGACACGCGAGGAGCCAAGCTTGCATGCCTGCA 3'
3' capture oligo;
5' AATTCGTAATCATGGTCATAGAGCACCCGTGCTACCGGAACG 3'
485; 5' TGATTACGAATTGGTGCAGGCATGCAAG 3'
PCR Primers:
596; 5' GGACGGGTCGACACGCGAGG 3'
789; 5' CGTTCCGGTAGCACGGG 3'
790; 5' GCCAAGCTTGCATGCCTG 3'
996; 5' GCTCTATGACCATGATTACG 3'
Polymerase chain reactions
All reactions were carried out in 50I buffer (10mM tris/HCl,
50mM KCI, 1.5mM MgCL2, 0.2mM each dATP/dTTP/dC-
TP/dGTP, 0.01 % w/v gelatin, 0.05% each Tween2O and NP40
detergents, pH8.3 at 25°C) using 2u Amplitaq enzyme and a
Hybaid Intelligent Heating Block on mode 2 (plate) control.
Denaturing steps were at 99°C for a duration of 2 minutes for
the first cycle and 45 seconds for the remaining cycles. Extension
reactions were done at 74°C for durations of 2 minutes for the
first ten cycles, 2.5 minutes for the second ten cycles and 3
minutes for any further cycles. Annealing steps were of 2 minutes
duration at 58°C for primers 596/789 and 52°C for primers
790/996.
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CSC Procedure
EcoRl/PstI digested DNA from mixture A was clo:
Ml3mpl8 (3). Template DNA was prepared as pr
described (4,5). 5' and 3' capture oligos were added
molar ratio to lkg of this template DNA in 401AX 10mM 1
1mM MgCl2 pH7.5 and the mixture heated to 65°C and
to cool to 37°C over approximately 30 minutes. To 1
unhybridised capture oligos, oligonucleotide 485 was the
in 1)iX H20, at a molar ratio to each capture oligo of 1(
mixture was left at 37°C for 15 minutes and then place(
15ltg mixture B DNA was digested with the enzy
EcoRIlPstI and then phenol, chloroform and ether extra
ethanol precipitated. Following resuspension in 50ltX I
sample was denatured by adding 501AX 0.34M NaOH an(
at 37°C for 30 minutes. 100,uX of a prechilled 1:1 mi
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NaCl, 50mM EDTA, 0. 1M tris/HCl pH7.8 and 9jtX foi
were added and the mixture allowed to anneal by sub
overnight in a 45°C waterbath. The sample was precipit
resuspended in 10,tX 0.5mM EDTA, 5mM tris/HCl p
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ligation was then performed at 16°C for 3 hours in 20tX 50mM
tris/HCl, 10mM MgCl2, 10mM dithiothreitol, ImM spermidine
and 1mM ATP pH7.4 using 0.5u T4 DNA ligase.
The ligated DNA was passed through a 1.3% alkaline agarose
gel (30mM NaOH, 2mM EDTA) from which fragments in the
0.15-0.5kb size range were recovered as gel slices to be diluted
twofold in H20 and melted at 65°C. 30 cycles of PCR were
performed upon 1fX aliquots of the liquified gel using primers
596/789. l1)X of each of these reactions was then further amplified
by 22 cycles of PCR using primers 790/996 and the products
recovered by preparative electrophoresis through a 1.3% neutral
agarose gel. Following EcoRIlPstI digestion these products were
cloned, by standard procedures, into the pBluescribe plasmid
vector (Statagene).
The CSC principle
edDNA A schematic representation of the CSC method applied to a pair
ethanol of DNA mixtures (A and B) is illustrated in figure 1. DNA
X of 4M fragments from mixture A are converted into short, orientated
rmamide and single stranded molecules with defined sequences at each
,merging end by first digesting with two restriction enzymes and then
tated and cloning into M13. The resulting mixture is called library A. A
H7.5. A pair of 'capture oligos' are then annealed to library A. Mixture
B is digested with the same restriction enzyme pair that were
used to process mixture A and then alkali denatured. Library
A and mixture B are combined and allowed to anneal in a reaction
driven to completion by the components of library A. Following
RE2 a ligation step, mixture B sequences are purified from those of
library A by preparative alkali agarose gel electrophoresis.
Coincident species are selectively recovered from this material
by employing the polymerase chain reaction (PCR) with primers
derived from the capture oligo sequences. PCR products are
finally cloned and analysed.
RESULTS
To evaluate the CSC procedure we employed human DNA and
DNA from the somatic cell hybrid iWi (6) (a human-mouse
hybrid with an intact chromosome 11 plus part of Xpter as the
sole human component) as mixtures A and B respectively, as
illustrated in figure 1.
F I F2 F3 F4 F5
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Noncoincident DNA
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Figure 1. Schematic Representation of the CSC Procedure. An explanation of
this figure is given in the text. Coincident DNA is indicated by the use of thicker
lines. Dotted lines indicate capture oligos. REI and RE2 represent any pair of
restriction enzymes.
Figure 2. Preparative Agarose Gel of Coincident DNA Fractions Fl-F5. Tracks
marked F1-F5 show the preparative separation of coincident DNA fractions F1-F5
respectively, following PCR amplification as described in Materials and Methods.
Bands recovered for the construction of product libraries are marked by solid bars.
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Library A
To produce library A, total human DNA was digested with the
enzyme pair EcoRI/PstI and fragments in the 0.15-0.5kb size
range were isolated by preparative electrophoresis upon a 1.3%
agarose gel for cloning into M13. 1,000 randomly selected
plaques were each inoculated into 1501d minicultures. These were
pooled for the preparation of single stranded DNA. 'Capture
oligos' were then annealed to this library.
Integration of library A and mixture B
15lg of EcoRJIPstI digested IWl DNA was reacted with Iltg
library A as detailed in the Materials and Methods. Following
the ligation step coincident sequences of 0.5kb down to 0.15kb
Table 1. CSC products examined and their product library of origin. Arrows
indicate the relationship between product libraries and CSC products.
PRODUCT NUMBER OF DISTINCT
LIBRARY CLONES EXAMINED PRODUCTS
1 4
1.2a
2 6
2a
3 3 , 3a
14 3-1, 3-15, 3-20
4 4 4a
5 2 5a
E_
_
in size were isolated as a set of five 100yd fractions labelled
Fl -F5 respectively. These fractions were individually amplified
by PCR and the main product bands (see figure 2) were recovered
and cloned to give CSC product libraries Fl -F5.
Analysis of CSC products
To analyse the CSC products, between 2 and 6 clones were
selected at random from each product library. Nitrocellulose lifts
of these colonies were probed with gel purified inserts derived
from miniprep plasmid DNA for each clone in order to identify
duplicated products. The 2 distinct isolates so obtained from
product library F3 were used as probes upon a further 22 library
F3 colonies enabling 14 non-hybridising colonies to be located.
From these a further 3 distinct products were similarly identified.
These results are summarised in table 1.
To establish the origin of each product, all isolates were used
to probe Southern blots of EcoRI digested human, mouse and
1Wl DNA in the absence ofhuman or mouse competitor DNA.
In all cases the probes were found to have been derived from
human sequences present within IWI, ie. from the DNA
coincident between mixtures A and B. In all but one case a single
hybridising band was detected with the exception showing
hybridisation to a high copy number repeat element later shown
to be the human LI repeat (7,8) (data not shown). Examples of
these results are shown in figure 3. By sequencing a portion of
each isolate, it was found that clone 2a and all the product library
F3 derived members shared a degree of homology ranging from
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Figure 3. Examples of Southern Analysis of CSC Products. Southern blots were
prepared from EcoRl digests of 7sg human DNA, 2Otg mouse DNA and 20Ag
IWI DNA. All CSC products were used as probes upon these blots employing
high stringency post-hybridisation washes. Results obtained with a unique sequence
product (4a) and an LI repeat sequence product (2a) are shown.
Figure 4. Southern Analysis of CSC Product 3a. Identical Southern blots were
prepared from EcoRI digests of 7ug human DNA, 20tg mouse DNA and 2Otg
IWI DNA. CSC product 3a was used to probe these blots employing 65°C post-
hybridisation washes in 0.1 % SDS at various salt concentrations as shown: A;
6xSSC, B; 0.5xSSC, and C; 0.1xSSC
a (Dcli rrE 0
x 2
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Table 2. Summary of results from Southern blot analysis of CSC products.
CSC HUMAN iWi SOUTHERN ANALYSIS
PRODUCT +ve? +ve? (high stringency)
1.2a + + Repeat
2a + + Unique
3a + + Unique
3-1 + + Unique
3-15 + + Unique
3-20 + + Unique
4a + + Unique
5a + + Unique
67% to 90% (data not shown). One such product was therefore
used to probe genomic blots under various stringencies (see figure
4). This family of products were thus shown to be members of
a previously unrecognised family of repeat elements, even though
they perform as distinct single copy probes upon Southern
analysis. These results are summarised in table 2.
DISCUSSION
The study described in this report was designed as a proof of
principle experiment for the CSC procedure. The evaluation of
any new technology requires the use of a test system which can
be easily analysed. In this respect the integration of human and
somatic cell hybrid DNA was an ideal system for the evaluation
of CSC because firstly, these resources represent highly complex
DNA and secondly, the products obtained could be readily
analysed by Southern analysis.
Two alternative approaches to the cloning of coincident DNA
have also been described (9,10). Unlike our scheme, both of these
are reported to produce a residual background of noncoincident
products. One method (9), is an in vivo system which promises
to be of general utility, but requires that both of the DNA samples
for integration be cloned into complementary vectors. The other
method (10), a second in vitro approach, is limited to the
examination of human inter-Alu sequences present within somatic
cell hybrids.
Our CSC method, like the alternatives, contains no specific
means for the predetermination of stringency, ie. for controlling
the degree of sequence match necessary for common elements
to be recovered. There is, however, an innate requirement in
our method for potential products to share approximate length
identity and to have identical 5' and 3' ends (to permit restriction
enzyme digestion and eventual ligation to the capture oligos).
The annealing conditions employed will also restrict the degree
of mismatch tolerable. Given these considerations, it is not
unreasonable to expect the current method to recover coincident
elements having marginally less than 100% sequence identity.
As part of the development of CSC we performed a number
of studies which were variations of the type of analysis described
in this report. In one case we repeated the experiment described
here but lowered the specificity of heteroduplex formation by
omitting formamide from the annealing buffer. Four products
were isolated in this experiment and these were shown to
represent a subset of the products obtained when including
formamide. Notably, a significantly greater degree of
amplification was required to produce these four products. One
possible reason for this could be that the desired formation of
matched heteroduplex was proceeding in competition with lower
specificity sequence pairing so causing a smaller amount of
material to become available for ligation to the capture oligos.
In a second experiment we utilised as library A, 300 human DNA
fragments of up to 2kb in size. Using longer extension times in
the PCR reactions we derived five products ranging in length
up to 1.2kb. This might indicate an intrinsic upper size limit to
the procedure which could be due to, for example, the genomic
distribution of short interspersed repeats.
The 8 products examined in this study are all coincident. In
light of the above considerations, those products of repetitive
nature could potentially have been 'captured' by highly related,
though nonidentical sequences in library A. Significantly, no
products were derived from the vast excess of mouse DNA (98%)
present in the hybrid genome. Noncoincident sequences from
library A were also not recovered since all products mapped back
to 1W l. This total absence of noncoincident products is consistent
with all our other studies.
The last stage of the CSC procedure involves bacterial
transformation with cloned PCR products. The size of the product
libraries one could make is therefore virtually unlimited. The
number of distinct products present within these libraries will
however have some limitation (for example, 50 of the 1,000
human fragments of library A should be present in lWi since
this comprises 5% of the human genome). The number of distinct
products we examined was not exhaustive, and, in the case of
product library F3, this was proven by expanding the initial 2
isolates to a group of 5 by simply examining more colonies.
Additional discrete F3 products have since been detected though
not yet thoroughly examined. It is reasonable to assume that the
same will apply to the other product libraries.
Three factors might have influenced the spectrum of coincident
products isolated; 1) the arbitrary higher level of analysis applied
to product library F3, 2) the pattern of EcoRl/PstI fragments
present in the 0.15-0.5kb size range examined and 3) variations
between sequences in their ease of amplification by PCR. We
anticipate that upon developing a means by which we can control
the stringency of the procedure, as discussed below, then both
the range and variety of sequences recovered will be increased.
To further develop our approach, a number of methodological
changes, designed to refine and simplify the procedure, are under
investigation. Firstly, we are increasing the size range of
molecules examined by simply modifying the PCR parameters.
Secondly, the M13 cloning step, employed to convert mixture
A into the orientated and single stranded DNA of library A, is
being replaced with PCR based alternatives. Thirdly, we are
investigating the use of single-strand specific modification and/or
degradation of annealed heteroduplex as a means for controlling
the stringency of the method.
CSC strategies promise to be useful in addressing a number
of molecular genetic problems. The procedure necessarily gives
rise to products which are relatively short due to its dependence
upon PCR amplification. Such fragments are of an ideal size for
sequencing in order to derive 'Sequence Tagged Site' (STS)
genomic markers (11). They are also of adequate length for
immediate use as hybridisation probes. For these reasons the CSC
scheme is intrinsically applicable to the analysis of genomic DNA.
For example, the procedure could be applied to the examination
of a panel of human clones derived from a somatic cell hybrid
to obtain a subset of these which are also present in a second
hybrid sharing only a small degree of overlap with the first. It
might also be possible to directly integrate DNA between species
to access conserved sequences of functional significance. Given
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an adequate means for stringency control, it might even be
possible to directly localise disease genes by integrating the DNA
of unrelated, affected individuals in order to identify sequences
in linkage disequilibrium with the mutant locus.
Aside from genomic DNA studies we believe that CSC could
be of great utility in allowing one to screen very large stretches
of genomic DNA (whether in its native state or cloned in a vector
system) for unknown coding sequences which exhibit a tissue
restricted expression profile by using an appropriate cDNA
resource as mixture B. The structural differences in sequence
between genomic DNA and cDNA due to the presence of introns
in the former could easily be overcome by employing frequent
cutting restriction enzymes to examine small fragments and then
focusing on the untranslated regions within cDNA which are
generally coded within large exons. Development of the CSC
procedure to address this problem is now underway.
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